Operational information

This data is publicly available. Parent page : ION-9935

Operational data for DKMS BMST Foundation India - ION-9935

Organisation Overview
The information has been reviewed in year :
Issuing organisation Number (ION)ION-9935
The Issuing Organisation Number of a organisation, this is globally unique number, as issued by the ICCBBA.
Time zoneAsia/Kolkata (GMT+05:30)
The timezone in which this organisation operates.
Business hours8:00 AM to 6:00 PM
The daily hours in which this organisation operates.
Work scheduleMonday - Friday
The normal work week in which this organisation operates.
Organisation closures
For all organisation closures, please see the WMDA Calendar.
Donor ID exampleOnly GRID is used for communication.
ID to be expected on paperwork, samples, and products.
Preliminary Search
Requires preliminary search request formNot applicable
If yes, form required can be found on the Documents Page.
Extended Typing
Typing options available for requestStandard: High Resolution: HLA-A, -B, -C,-DRB1,-DQB1, -DPB1; Upon Request: HLA-DRB3/4/5, -DQA1, -DPA1), as well as KIR, CCR5, HLA-E and MICA/-B
Please note special requirements listed
Requires organisation specific typing request formNot applicable
If yes, form required can be found on the Documents Page.
Number of days donor is reserved for a patient after a requestNo reservation after Extended Typing request.
Verification Typing
Maximum blood volume allowed50 ml
Requires organisation specific typing request formNot applicable
If yes, form required can be found on the Documents Page.
IDM testing performed at verificationYes
Number of days donor is reserved for a patient after a request90 days
Sibling Typing
Registry is willing to arrange sibling typingsYes
If yes, procedure to apply for sibling typings Send documents to familydonors@dkms.org.
Workup Request
Product dosage limitPBSC: CD 34+ 5x10^6/kg bodyweight recipient
Number of donor cells allowed based on recipient weight.
Requires patient to meet certain standards in order to proceed with collectionYes
Organisation may or may not allow donor collections for some patients.
Patient physician must report the following in order to proceed with collectionFor compasionate therapy an ethical review board approval is required and the medical advisor need to approve it. Patient must be less than 85 years old.
Must provide additional information to organisation.
Requires organisation specific work up forms Not applicable
If yes, form(s) required can be found on the Documents Page.
Workup IDM completed 30 days prior to collectionYes
Donor IDM results must be performed within 30 days of collection date to be valid and allow the collection to proceed.
Medical Health Questionnaire example available
If yes, the example can be found on the Documents Page.
Post-Transplant
Subsequent donation policyDonors are not allowed to donate any type of donation within 6 months after a peripheral stem cell harvest due to Indian law. Consequently, we recommend to consider a higher cells content when a HSC product is requested, and to reserve a volume for cryopreservation in case of a second transplant requirement. All subsequent donation requests have to be approved by our medical advisors. For more information please see DKMS Operational User Guide.
Anonymous contact allowedyes
Direct contact allowedAllowed at the earliest two years after transplantation or one year after a second donation, if patient and donor agree and sign a declaration of consent.
Gift exchange allowedYes, 1 gift per donor or recipient. No waiting period post transplant, value max 20€.
Cord blood contact allowedNot applicable

Regulatory information

The data provided on this page is updated by the organisations.
The WMDA makes no representations or express or implied warranties regarding any information on this page.
Use of any information provided on this site does not and is not intended to create a contractual or other relationship.

General

The information has been reviewed in year :2024
Organisation name:DKMS BMST Foundation India
Organisation ION:ION-9935
Country:India
Year the registry started operations:November 2015

Products

comment
Do you provide HPC, Marrow? no
Do you provide HPC, Apheresis? yes
Do you provide HPC, Cord Blood? no
Do you provide MNC, Apheresis? yes Donors are not allowed to donate any type of donation within 6 months after a peripheral stem cell harvest due to Indian law.
Do you provide NC, Whole Blood? no

Product quantity

Data valid for year2023
Number of products NationalInternational
HPC, Marrow products: 0 0
HPC, Apheresis: 33 6
HPC, Cord: 0 0

License

Organisation is licensed/accredited by the Competent Authority:no
Comment:Not applicable in India
Name of Competent Authority:
Date of last inspection:
Link to website of Competent Authority:
Can you provide the Legal documentation from the Competent Authority that your organisation is allowed to operate as a registry ?
Is your registry WMDA Certified, WMDA Qualified or WMDA Accredited?WMDA Qualified
The registry is accredited by any other organisation:no
If yes, by which organisation?WMDA Qualified through DKMS-Registry (ION-4596). WMDA Full Standards Certification via DKMS Registry planned in Q4 2024

Affiliation

The registry works with the following number of affiliated donor centres:Not applicable
The registry audits its donor centres:Not applicable
The registry works with the following numer of affiliated collection centres:3
Ther registry audits its collection centres:Initial evaluation before starting operation. Regular evaluation is about to be implemented.
The registry works with the following number of affiliated Cord Blood Banks:0
The registry audits its Cord Blood Banks:Not applicable
The registry works with the following number of affiliated transplant centres:0
The registry audits its transplant centres:Not applicable
The registry works with the following number of affiliated IDM Testing Laboratories:2
The registry audits its IDM Testing Laboratories:No. IDM laboratory is accredited by NABL
The registry works with the following number of affiliated HLA/other DNA markers testing laboratories:1
The registry audits its HLA/other DNA markers testing laboratories:No. HLA laboratory is accredited by EFI.
The registry would be able to provide a full list of name/addresses of each affiliated and their licence/accreditation status, on request: yes
The Cord Blood Banks are FACT-NetCord accredited:no
If yes, the following Cord Blood Bank(s) are accredited:
The registry is able to provide a copy of all the certificates: yes
Affiliated centres comply with WMDA Standards and applicable national regulations: yes
The registry has requirements for affiliated centres in addition to WMDA Standards and applicable national regulations: yes
If yes, what are these requirements?Comply as per national regulations- Drugs and Cosmetics Rules, 1945

Donor policy

All donors are unpaid volunteers: yes
All donors are informed about donation process and associated risks: yes
Donors sign a valid informed consent to donate in the presence of a medical doctor/health care personnel/registry staff: yes
The registry has systems in place to protect and control access to donor/patient records: yes
The registry maintains donor anonymity: yes
The registry has detailed donor evaluation and exclusion criteria in place: yes
The registry has donor evaluation and exclusion criteria that do meet or exceed the WMDA guidelines: yes

IDM

IDM TestedMethod Days between test
and sampling/workup
ALT/ASTALT/AST ratio, De-Ritis-Quotient YesBiochemistry<30 days
ChagasChagas, T. cruzi -
CMV IgGCytomegalovirus (CMV) Antibody testing IgG YesELISA<30 days
CMV IgMCytomegalovirus (CMV) Antibody testing IgM YesELISA<30 days
CMV TotalCytomegalovirus Total On requestELISA<30 days
EBV IgGEpstein-Barr Virus Antibody testing IgG YesELISA<30 days
EBV IgMEpstein-Barr Virus Antibody testing IgM YesELISA<30 days
HAV (NAT)Anti-hepatitis A virus nucleic acid testing -
HBV (NAT)Hepatitis B nucleic acid testing YesPCR/TMA<30 days
HBc AbHepatitis B core antibody testing YesELISA / CLIA<30 days
HBs AgHepatitis B Surface antigen testing YesELISA / CLIA<30days
HCV (NAT)Hepatitis C nucleic acid testing YesPCR/TMA<30 days
HCV AbHepatitis C antibody testing YesELISA /CLIA<30 days
HEV (NAT)Hepatitis E Virus nucleic acid testing -
HIV (NAT)Human Immunodeficiency Virus nucleic acid testing YesPCR/TMA<30 days
HIV-1 AbHuman Immunodeficiency Virus HIV-1 antibody testing YesELISA /CLIA<30 days
HIV-2 AbHuman Immunodeficiency Virus HIV-2 antibody testing YesELISA / CLIA<30 days
HIV p24Human Immunodeficiency Virus p24 antigen testing No
HTLV-IHuman T-Lymphotropic Virus type I testing YesELISA<30 days
HTLV-IIHuman T-Lymphotropic Virus type II testing YesELISA<30 days
MalariaMalaria YesQuantitative Buffy Coat (QBC)<30 days
HSVHerpes Simplex Virus -
STSSerological tests for syphilis YesTPHA<30 days
STS FTA-ABSSerological test for syphilis On requestFTA<30 days
ToxoplasmosisToxoplasmosis YesELISA<30 days
VZVVaricella Zoster Virus -
WNV-NATWest Nile Virus nucleic acid testing No
Other tests performed Yesirregular AB <30 days

Testing

The physical and medical exam at donor workup is performed by a medical doctor: yes
All donor testing (at workup) for infectious disease is performed in a laboratory certified/licensed by a Competent Authority: yes
HLA typing for patient specific request is performed in an appropriately accredited laboratory: yes
Sterility testing is performed on the adult donor product: yes
Sterility testing is performed on the cord blood product:no
Screening questionnaire to exclude communicable disease: yes
Screening questionnaire to exclude donors with 'high risk' lifestyles: yes
Donor reliability identified by a medical doctor: yes
Donor clearance to donate is confirmed by a medical doctor, following as a minimum the donor exclusion criteria in Annex 1 of EU Directive 2006/17/EC :

The party providing the cell product must exclude donors when:

  • They are pregnant;
  • They are breastfeeding;
  • There is the potential for transmission of inherited conditions;
  • There is evidence of any other risk factors for transmissible diseases on the basis of a risk assessment, taking into consideration Donor travel and exposure history and local infectious disease prevalence;
  • There is presence on the donor’s body of physical signs implying a risk of transmissible disease(s);
  • There is a history of a disease of unknown aetiology;
  • There is a risk of transmission of diseases caused by prions;
  • There is systemic infection which is not controlled at the time of donation, including bacterial diseases, systemic viral, fungal or parasitic infections, or significant local infection in the tissues and cells to be donated;
  • There is history of chronic, systemic autoimmune disease that could have a detrimental effect on the quality of the Cell Product;
  • There is recent history of vaccination with a live attenuated virus where a risk of transmission is considered to exist;
  • There is ingestion of, or exposure to, a substance (such as cyanide, lead, mercury, gold) that may be transmitted to recipients in a dose that could endanger their health.
 yes

Customs regulations

Are there any customs regulations to follow, or customs paperwork required, to import cell products into the organisation country? If yes, please specify:Transplant centre has to provide 12-B form (Permit for the import of small quantities of drugs for personal use), entry letter for the courier, workup forms and information about person who will meet the courier at the airport.
Are there any customs regulations to follow, or customs paperwork required, to export cell products from the organisation country? If yes, please specify:Basic paperwork, Statement of Necessity, Authorization and Declaration Letter
Are there any import regulations to follow, or paperwork required, to import cell products into the organisation country? If yes, please specify:
Are there any export regulations to follow, or paperwork required, to export cell products from the organisation country? If yes, please specify:

Reporting of Serious Adverse Events

Please indicate which of the following schemes for reporting Serious Adverse Events relating to either the Donor or the product the Registry participates in:
- Mandatory National Reporting Scheme
- Voluntary National Reporting Scheme
- WMDA SEAR/SPEAR Reporting Scheme yes
The registry will notify the receiving Registry within 24 hours of receiving information relating to any serious adverse event that could be considered to affect the patient receiving the product: yes

Quality management

The registry does maintain Standard Operating Procedures for your work: yes
The registry would be willing to provide these to WMDA or another registry upon request: yes
The registry would be willing to provide WMDA or another registry, on request, with copies of any packaging the HPC product will arrive in: yes
Donor records relating to the medical exam and HPC collection process are the following number(s) of year(s) retained:5 years

  • No labels